2. Academic Validation
  3. Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration

Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration

  • EMBO Mol Med. 2016 Mar 1;8(3):176-90. doi: 10.15252/emmm.201505894.
Dario Brunetti 1,  Janniche Torsvik 2,  Cristina Dallabona 3,  Pedro Teixeira 4,  Pawel Sztromwasser 5,  Erika Fernandez-Vizarra 1,  Raffaele Cerutti 1,  Aurelio Reyes 1,  Carmela Preziuso 6,  Giulia D'Amati 6,  Enrico Baruffini 3,  Paola Goffrini 3,  Carlo Viscomi 1,  Ileana Ferrero 3,  Helge Boman 7,  Wenche Telstad 8,  Stefan Johansson 9,  Elzbieta Glaser 4,  Per M Knappskog 9,  Massimo Zeviani 10,  Laurence A Bindoff 11
Affiliations

Affiliations

  • 1 MRC Mitochondrial Biology Unit, Wellcome Trust, Cambridge, UK.
  • 2 Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • 3 Department of Life Sciences, University of Parma, Parma, Italy.
  • 4 Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
  • 5 Department of Clinical Science, University of Bergen, Bergen, Norway Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway.
  • 6 Department of Radiological, Oncological and Pathological Sciences Sapienza University of Rome, Rome, Italy.
  • 7 Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
  • 8 Department of Neurology, Førde Hospital, Førde, Norway.
  • 9 Department of Clinical Science, University of Bergen, Bergen, Norway Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
  • 10 MRC Mitochondrial Biology Unit, Wellcome Trust, Cambridge, UK [email protected] [email protected].
  • 11 Department of Neurology, Haukeland University Hospital, Bergen, Norway Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway [email protected] [email protected].
PMID: 26697887 DOI: 10.15252/emmm.201505894
Abstract

Mitochondrial dysfunction and altered proteostasis are central features of neurodegenerative diseases. The pitrilysin metallopeptidase 1 (PITRM1) is a mitochondrial matrix Enzyme, which digests oligopeptides, including the mitochondrial targeting sequences that are cleaved from proteins imported across the inner mitochondrial membrane and the mitochondrial fraction of amyloid beta (Aβ). We identified two siblings carrying a homozygous PITRM1 missense mutation (c.548G>A, p.Arg183Gln) associated with an autosomal recessive, slowly progressive syndrome characterised by mental retardation, spinocerebellar ataxia, cognitive decline and psychosis. The pathogenicity of the mutation was tested in vitro, in mutant fibroblasts and skeletal muscle, and in a yeast model. A Pitrm1(+/-) heterozygous mouse showed progressive ataxia associated with brain degenerative lesions, including accumulation of Aβ-positive amyloid deposits. Our results show that PITRM1 is responsible for significant Aβ degradation and that impairment of its activity results in Aβ accumulation, thus providing a mechanistic demonstration of the mitochondrial involvement in amyloidotic neurodegeneration.

Keywords

amyloid beta; mitochondrial disease; mitochondrial targeting sequence; neurodegeneration; pitrilysin 1.

Figures